COVID-19 and health systems in Brazil and around the world: effects on the working conditions and health of health workers

Antônio Vieira Machado Wagner Eduardo Ferreira Marco Antônio de Ávila Vitória Helvécio Miranda Magalhães Júnior Letícia Lemos Jardim Marco Antônio Carneiro Menezes Renato Penha de Oliveira Santos Filipe Leonel Vargas Everson Justino Pereira About the authors

Abstract

This article discusses the impacts of the COVID-19 pandemic on health systems and its effects on the working conditions and mental health of health professionals and invisible health workers. It presents data on deaths among health professionals, highlighting the need for better and safer working conditions and improvements in public management. We emphasize WHO/PAHO recommendations and the need for equitable vaccine distribution, including poor countries and vulnerable populations. We also highlight the impacts of interrupting essential health services, such as the treatment of chronic conditions and infectious disease prevention, and the damage caused by the dissemination of fake news, stressing the need to improve access to correct and safe health information.

Key words:
Pandemic; COVID-19; Health; Health professional; Death; Infodemic

Introduction

To contribute to the reflection proposed in this article it is important to first provide a succinct retrospective of the episodes that defined the course of the public health emergency caused by the COVID-19 pandemic. The novel coronavirus (SARS-CoV-2) was first reported by the World Health Organization (WHO) on 31/12/2019, a week after the first patient was diagnosed and admitted to Wuhan Central Hospital in the province of Hubei, China on 26/12/201911 Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. A new coronavirus associated with human respiratory disease in China. Nature 2020; 579(7798):265-269..

On 10/01/2020, scientists performed the first sequencing of the Wuhan CoV genome (WH- Human1). On 30/01/2020, the WHO declared the novel coronavirus a public health emergency of international concern and on 11/03/2020 the outbreak was characterized as a pandemic, with 110,000 cases across 114 countries.

In Brazil, in January 2020, the Ministry of Health Center for Strategic Information on Health Surveillance (CIEVS), which is part of the National Public Health Emergency Alert and Response Network, was notified of the first suspected cases of COVID-19. Ministerial Order 188 (03/02/2020) declared COVID-19 a Public Health Emergency of National Significance (ESPIN)22 Brasil. Ministério da Saúde (MS). Portaria nº 188, de 3 de fevereiro de 2020. Declara Emergência em Saúde Pública de importância Nacional (ESPIN) em decorrência da Infecção Humana pelo novo Coronavírus (2019-nCoV). Saúde Legis 2020; 3 fev. and Law 13979 (6/02/2020) created measures to respond to the ESPIN caused by the coronavirus responsible for the outbreak in 201933 Brasil. Lei 13.979, de 6 de fevereiro de 2020. Dispõe sobre as medidas para enfrentamento da emergência de saúde pública de importância internacional decorrente do coronavírus responsável pelo surto de 2019. Diário Oficial da União 2020; 6 fev..

Seven human coronaviruses (HCoVs) have been identified to date: HCoVs-229-E, OC43, NL63, HKV1, SARS-CoV (severe acute respiratory syndrome), MERS-CoV (Middle East respiratory syndrome) and SARS-CoV-2 (novel coronavirus). The knowledge base of the family of coronaviruses acquired over the years has been extremely valuable in improving our understanding of and response to the pandemic. However, the unpreparedness of health systems was a determining factor in the outcome of the pandemic.

On 26/02/2020, Brazilian researchers completed the genomic sequencing of the first case of coronavirus in Latin America. This sequencing was of utmost importance. providing data to monitor the pandemic, detect mutations and inform the manufacturing of vaccines44 Genoma do SARS-CoV-2 do primeiro caso de COVID-19 da América Latina sequenciado em 48 horas no Instituto Adolfo Lutz [Internet]. Faculdade de Medicina da USP 2020. [acessado 2022 fev 8]. Disponível em: https://www.fm.usp.br/fmusp/noticias/-genoma-do-sars-cov-2-do-primeiro-caso-de-covid-19-da-america-latina-sequenciado-em-48-horas-no-instituto-adolfo-lutz
https://www.fm.usp.br/fmusp/noticias/-ge...
. However, disinformation and the large-scale spread of fake news on the topic created fertile ground for the emergence of miracle cures and non-adherence to effective health measures.

Despite the adverse circumstances, the WHO and Pan American Health Organization (PAHO) worked to provide technical support, recommending that countries kept surveillance systems on constant alert and maintained the early identification and isolation of patients. Everything was new and planning of the response to the pandemic was ad hoc. Today we have a clearer understanding of the complex clinical manifestations of COVID-19 and best treatment strategies. Nonetheless, the COVID-19 pandemic became an unprecedented calamity, whose effects have yet to be fully estimated.

The present study explores the repercussions of the COVID-19 pandemic within health systems in Brazil and around the world and its effects on the working conditions and mental health of frontline health workers. Finally, we analyze the social and work-related impact of the widespread dissemination of fake news about the topic (infodemic).

Methodology

We conducted an exploratory descriptive reflective study using data derived from searches of the following sources: the databases PubMed, Lilacs, EBSCOhost, SciELO, Bireme, Scopus, BVS, Google Scholar; DATASUS, Ministry of Health, PAHO and WHO websites; and news websites, television news programs and the critical press. The data were synthesized and scrutinized using content analysis and drawing on the studies “Working Conditions of Health Professionals in Brazil within the Context of COVID-19” and “Invisible Health Workers: Working Conditions and Mental Health in Brazil in the Context of COVID-19”, coordinated by Professor Maria Helena Machado, CEE/ENSP/FIOCRUZ.

COVID-19 pandemic response overview

Global overview

The infection caused by SARS CoV-2 was the first great pandemic of the twenty-first century. Since its identification in China at the end of 2019, there have been more than 755 million cases of the disease and around 6.8 million deaths across 231 countries and territories55 COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet 2022; 399(10334):1513-1536.. Not even remote and sparsely populated regions such small islands in the Western Pacific region or Antarctic have been spared. It is estimated that the true figures are 3 to 4 times higher than official numbers66 Gill I, Schellekens P. COVID-19 is a developing country pandemic [Internet]. 2021. [cited 2022 maio 27]. Available from: https://pandem-ic.com/blog-covid-19-is-a-developing-country-pandemic/
https://pandem-ic.com/blog-covid-19-is-a...
. Approximately 90% of global COVID-19 deaths were in low- and medium-income countries (with numbers being 3 to 6 times higher than in high-income countries) and these nations have seen a significant increase in the proportion of deaths among younger age groups and people without comorbidities88 Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management BMJ 2021; 374:n1648. (Graph 1).

Graph 1
Worlwide confirmed cases of COVID-19 by region.

In addition to older people and individuals with immunodeficiency or multiple comorbidities, children and pregnant women should receive timely vaccination.

COVID-19 showed itself to be a much more complex disease than initially thought as the pandemic progressed, frequently presenting hyperinflammatory multisystem manifestations followed by serious chronic complications, even in younger people and individuals without comorbidities. These chronic complications have been described as “long COVID”, characterized by a set of more than 20 symptoms that persist after the acute phase of the disease99 Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol 2022; 322(1):C1-C11.,1010 Davis HE, Assaf GS, McCorkell L, Wei H, Baixo RJ, Re'em Y, Redfield S, Austin JP, Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021; 38:101019.. Longitudinal studies estimate that long COVID can affect up to 50% of patients to a varying degree and have a significant impact on quality of life, requiring a multidisciplinary approach1010 Davis HE, Assaf GS, McCorkell L, Wei H, Baixo RJ, Re'em Y, Redfield S, Austin JP, Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021; 38:101019..

A global epidemiological study showed that risk of COVID-19 hospitalization and death and chance of infection was 50 times and 15 times lower, respectively, in fully vaccinated people1111 Johnson AG, Amin AB, Ali AR, Hoots B, Cadwell BL, Arora S, Avoundjian T, Awofeso AO, Barnes J, Bayoumi NS, Busen K, Chang C, Cima M, Crockett M, Cronquist A, Davidson S, Davis E, Delgadillo J, Dorabawila V, Drenzek C, Eisenstein L, Fast HE, Gent A, Hand J, Hoefer D, Holtzman C, Jara A, Jones A, Kamal-Ahmed I, Kangas S, Kanishka F, Kaur R, Khan S, King J, Kirkendall S, Klioueva A, Kocharian A, Kwon FY, Logan J, Lyons BC, Lyons S, May A, McCormick D; MSHI; Mendoza E, Milroy L, O'Donnell A, Pike M, Pogosjans S, Saupe A, Sell J, Smith E, Sosin DM, Stanislawski E, Steele MK, Stephenson M, Stout A, Strand K, Tilakaratne BP, Turner K, Vest H, Warner S, Wiedeman C, Zaldivar A, Silk BJ, Scobie HM. COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of delta and omicron variant emergence - 25 U.S. jurisdictions April 4-December 25, 2021. MMWR Morb Mortal Wkly Rep 2022; 71(4):132-138.. Despite unequal access to vaccines in different parts of the planet, especially in Africa, it is estimated that mass vaccination against COVID-19 has avoided more than 20 million deaths worldwide1212 Watson OJ, Barnsley G, Toor J, Hogan AB, Wisnkill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Inf Dis 2022; 22(9):1293-302.. However, it is estimated that one million additional lives could have been saved with vaccine sharing across low- and middle-income countries1313 Moore S, Hill EM, Dyson L, Tildesley M.J, Keeling MJ. Retrospectively modeling the effects of increased global vaccine sharing on the COVID-19 pandemic. Nature Med 2022; 28(11):2416-2423., with the impact of the pandemic being higher on socially and economically vulnerable individuals and groups. Figure 1 clearly demonstrates inequalities in the distribution and onset of vaccination around the world.

Figure 1
World COVID-19 vaccination map.

The pandemic is not over. In November 2022, COVID-19 was the fourth leading cause of death worlwide, with 5.1 million deaths over the last 12 months (49% in the poorest half of the world). Moreover, 2.4 billion people have not been vaccinated (70% in the poorest half of the world) and booster coverage is 33% worldwide (15% in the poorest half of the world). In other words, the pandemic continues to affect poor countries disproportionately77 Schellekens P. The demographics of excess mortality [Internet]. 2022. [cited 2022 ago 9]. Available at: https://pandem-ic.com/the-demographics-of-excess-mortality/
https://pandem-ic.com/the-demographics-o...
,88 Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management BMJ 2021; 374:n1648. (Figure 2).

Figure 2
WHO Global Health Emergency Dashboard.

The pandemic has had a huge direct and indirect impact on health services worldwide1414 Omboni S, Padwal RS, Alessa T, Benczúr B, Green BB, Hubbard I, Kario K, Khan NA, Konradi A, Logan AG, Lu Y, Mars M, McManus RJ, Melville S, Neumann CL, Parati G, Renna NF, Ryvlin P, Saner H, Schutte AE, Wang J. Connect Health 2022; 1:7-35.. The rapid increase in demand for consultations and hospital admission during the acute phase of the pandemic overwhelmed health services and professionals. To avoid health system collapse, it was necessary to reduce other services such as the diagnosis and routine screening of diseases like tuberculosis, diabetes, high blood pressure and certain types of neoplasms, adversely affecting the prevention and treatment of these diseases. Mother and infant care and immunization programs were also affected. As a result, an increase in vaccine preventable diseases is expected in the short- to medium-term1414 Omboni S, Padwal RS, Alessa T, Benczúr B, Green BB, Hubbard I, Kario K, Khan NA, Konradi A, Logan AG, Lu Y, Mars M, McManus RJ, Melville S, Neumann CL, Parati G, Renna NF, Ryvlin P, Saner H, Schutte AE, Wang J. Connect Health 2022; 1:7-35..

Evidence shows that social distancing also had an impact on mental health, leading to increased incidence of obesity, sedentarism, and alcohol and drug abuse during the acute phase of the pandemic. On the other hand, the use of innovative digital health strategies such as telemedicine has expanded. These technologies will need to be kept updated in the post-pandemic period1515 United Nations Children's Fund (UNICEF), United Nations Educational, Scientific and Cultural Organization (UNESCO), World Bank. Where are we on education recovery? New York: UNICEF; 2022..

National overview

In Brazil, the fact that the country has a universal health system and vast experience in responding to epidemics should be an advantage when it comes to combatting COVID-191616 Croda J, Oliveira WK, Frutuoso RL, Mandetta LH, Silva DCB, Sousa JDB, Monteiro WM, Lacerda MVG. COVID-19 in Brazil: advantages of a socialized unified health systemand preparation to contain cases. Rev Soc Bras de Med Trop 2020; 53: e20200167.,1717 Wakimoto MD, Menezes RC, Pereira SA, Nery T, Castro-Alves J, Penetra SLS, Ruckert A, Labonté R, Veloso VG. COVID-19 and zoonoses in Brazil: environmental scan of one health preparedness and response. One Health 2022; 14:100400.. Brazil is a country of continental proportions characterized by deep social and regional disparities, and approximately 80% of the population depend exclusively on the public health system, o Sistema Único de Saúde (SUS) or Unified Health System. The pandemic reproduced social inequalities, disproportionately affecting more vulnerable groups.

In response to the omission of the federal government and dreadful management during the pandemic, state and municipal health managers were forced to develop their own strategies to contain the rapid spread of the disease. Measures include the establishment of a pandemic response committee, with regular meetings to guide municipal health managers and the population in a timely, precise and transparent manner1818 Tasca R, Carrera MBM, Malik AM, Schiesari LMC, Bigoni A, Costa CF, Massuda A. Gerenciando o SUS no nível municipal ante a COVID-19: uma análise preliminar. Saude Debate 2022; 46(esp. 1):15-32.. Partnerships with health professionals and educational institutions were of paramount importance, enabling decision-making based on sound epidemiological data1717 Wakimoto MD, Menezes RC, Pereira SA, Nery T, Castro-Alves J, Penetra SLS, Ruckert A, Labonté R, Veloso VG. COVID-19 and zoonoses in Brazil: environmental scan of one health preparedness and response. One Health 2022; 14:100400..

Initiatives outside the SUS, such as the Oswaldo Cruz Foundation’s MonitoraCOVID-191919 Fundação Oswaldo Cruz (Fiocruz). Instituto de Comunicação e Informação Científica e Tecnológica em Saúde (ICICT) [Internet]. MonitoraCovid-19. 2020. [acessado 2023 jan 26] Disponível em: https://bigdata- covid19.icict.fiocruz.br/
https://bigdata- covid19.icict.fiocruz.b...
and press consortium provided unified and reliable information on COVID-19 trends. Case and death surveillance indicators were created and revised; however, difficulties tracking cases, particularly asymptomatic cases, undermined contingency planning2020 Massuda A, Malik AM, Vecina G, Tasca R, Ferreira-Júnior WC. A resiliência do Sistema Único de Saúde frente à COVID-19. Cad EBAPE.BR 2021; 19(esp.):735-744..

In 2022, Brizzi et al.2121 Brizzi A, Whittaker C, Servo LMS, Hawryluk I, Prete Jr CA, Souza WM, Aguiar RS, Araujo LJT, Bastos LS, Blenkinsop A, Buss LF, Candido D, Castro MC, Costa SF, Croda J, de Souza Santos AA, Dye C, Flaxman S, Fonseca PLC, Geddes VEV, Gutierrez B, Lemey P, Levin AS, Mellan T, Bonfim DM, Miscouridou X, Mishra S, Monod M, Moreira FRR, Nelson B, Pereira RHM, Ranzani O, Schnekenberg RP, Semenova E, Sonabend R, Souza RP, Xi X, Sabino EC, Faria NR, Bhatt S, Ratmann O. Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals. Nat Med 2022; 28(7):1476-1485. analyzed COVID-19 hospital mortality rates in 14 capital cities during the second wave of the pandemic, revealing regional, socioeconomic and health resource disparities before and during the pandemic. Deaths were lower in capitals with more well-structured hospital systems and higher bed availability, reinforcing the importance of health care and crisis preparedness. The study estimated that approximately half of hospital deaths due to COVID-19 could have been avoided if the country had had an even response structure, without pre-pandemic regional inequities and pandemic healthcare pressure, and with continued structuring of the SUS across all levels of health care and strong regulation and management.

Social distancing required the reorganization of health care, including point of entry, rearguard and emergency services. With regard to face-to-face services, the largely precarious physical spaces of the country’s more than 40,000 primary health care centers had to be redesigned to prevent transmission, separating COVID and “non- COVID” patients2222 Lavras C. Atuação das equipes de APS durante o período de enfrentamento da COVID-19. In: Conselho Nacional de Secretários de Saúde (CONASS). Profissionais de saúde e cuidados primários. Brasília: CONASS; p. 13-24. Within this context, the relationship of trust between family health teams and the community was an important ally in the dissemination of correct information and adherence to preventions measures. Data on health regions enabled the identification of individuals from vulnerable groups and with comorbidities, facilitating the planning of treatment and even social isolation. However, inadequate infrastructure and facilities and the poor quality of the information available during this phase presented significant barriers to health care.

Virtual consultation and remote diagnosis technologies such as telehealth were adopted, improving screening of mild cases and health worker and patient safety2323 Caetano R, Silva AB, Guedes ACCM, Paiva CCN, Ribeiro GR, Santos DL, Silva RM. Desafios e oportunidades para telessaúde em tempos da pandemia pela COVID-19: uma reflexão sobre os espaços e iniciativas no contexto brasileiro. Cad Saude Publica 2020; 36(5):e00088920.. However, this process was hampered by poor organizational culture, lack of training, legal uncertainties and limited access to technology2020 Massuda A, Malik AM, Vecina G, Tasca R, Ferreira-Júnior WC. A resiliência do Sistema Único de Saúde frente à COVID-19. Cad EBAPE.BR 2021; 19(esp.):735-744.. In view of these difficulties, the pandemic response reinforced the need for coordination across all levels of care to strengthen the SUS.

In January 2020, the Public Health Emergency Operations Center for the new Coronavirus (COE-nCoV) was created and real-time PCR testing was standardized in accordance with WHO protocols1515 United Nations Children's Fund (UNICEF), United Nations Educational, Scientific and Cultural Organization (UNESCO), World Bank. Where are we on education recovery? New York: UNICEF; 2022.. Initially tests were offered by a limited number of laboratories through public-private partnerships, prioritizing hospital patients1616 Croda J, Oliveira WK, Frutuoso RL, Mandetta LH, Silva DCB, Sousa JDB, Monteiro WM, Lacerda MVG. COVID-19 in Brazil: advantages of a socialized unified health systemand preparation to contain cases. Rev Soc Bras de Med Trop 2020; 53: e20200167. and later individuals with flu-like signs and symptoms2222 Lavras C. Atuação das equipes de APS durante o período de enfrentamento da COVID-19. In: Conselho Nacional de Secretários de Saúde (CONASS). Profissionais de saúde e cuidados primários. Brasília: CONASS; p. 13-24,2424 Kameda K, Barbeitas MM, Caetano R, Löwy I, Oliveira ACD, Corrêa MCDV, Cassier M. Testing COVID-19 in Brazil: fragmented efforts and challenges to expand diagnostic capacity at the Brazilian Unified National Health System. Cad Saude Publica 2021; 37(3):e00277420..

The COVID-19 pandemic placed unprecedented pressure and stress on the health system. The number of hospitals with intensive care units (ICUs), ventilators and qualified professionals was insufficient to meet patient demand across all regions, especially in the North and Northeast2525 Cotrim Júnior DF, Cabral LMS. Crescimento dos leitos de UTI no país durante a pandemia de COVID-19: desigualdades entre o público X privado e iniquidades regionais. Physis 2020; 30(3):e300317.,2626 Passos VMA, Brant LCC, Pinheiro PC, Correa PRL, Machado IE, Santos MR, et al. Higher mortality during COVID-19 pandemic in socially vulnerable areas in Belo Horizonte: implications for vaccination priority. Rev Bras Epidemiol 2021; 24:e210025..

The beginning of the pandemic saw the spread of treatments without evidence and not approved or recommended by government and international health bodies. The Federal Medical Council (Consultation CFM 8/2020, report CFM 4/2020) authorized the prescription of hydroxychloroquine for mild cases of COVID-19 with patient consent in April 20202727 Conselho Federal de Medicina (CFM). Processo-consulta CFM nº 8/2020 - Parecer CFM nº 4/2020. Considerar o uso da cloroquina e hidroxicloroquina, em condições excepcionais, para o tratamento da COVID-19 [Internet]. 2020. Disponível em: https://saude.mppr.mp.br/arquivos/File/Corona/CFM/6.pdf
https://saude.mppr.mp.br/arquivos/File/C...
, despite the lack of scientific evidence to support its effectiveness.

Various studies highlighted that there was no evidence supporting the effectiveness of the medicines that made up the “COVID kit”, either individually or in combination2828 Cavalcanti AB, Zampieri FG, Rosa RG, Azevedo LCP, Veiga VC, Avezum A, Damiani LP, Marcadenti A, Kawano-Dourado L, Lisboa T, Junqueira DLM, de Barros E Silva PGM, Tramujas L, Abreu-Silva EO, Laranjeira LN, Soares AT, Echenique LS, Pereira AJ, Freitas FGR, Gebara OCE, Dantas VCS, Furtado RHM, Milan EP, Golin NA, Cardoso FF, Maia IS, Hoffmann Filho CR, Kormann APM, Amazonas RB, Bocchi de Oliveira MF, Serpa-Neto A, Falavigna M, Lopes RD, Machado FR, Berwanger O; Coalition Covid-19 Brazil I Investigators. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate COVID-19. N Engl J Med 2020; 383(21):2042-2052.

29 Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, Ustianowski A, Elmahi E, Prudon B, Whitehouse T, Felton T, Williams J, Faccenda J, Underwood J, Baillie JK, Chappell LC, Faust SN, Jaki T, Jeffery K, Lim WS, Montgomery A, Rowan K, Tarning J, Watson JA, White NJ, Juszczak E, Haynes R, Landray MJ. Effect of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 2020; 383(21):2030-2040.

30 Siemieniuk RA, Bartoszko JJ, Zeraatkar D, Kum E, Qasim A, Martinez JPD, Izcovich A, Lamontagne F, Han MA, Agarwal A, Agoritsas T, Azab M, Bravo G, Chu DK, Couban R, Devji T, Escamilla Z, Foroutan F, Gao Y, Ge L, Ghadimi M, Heels-Ansdell D, Honarmand K, Hou L, Ibrahim Q, Khamis A, Lam B, Mansilla C, Loeb M, Miroshnychenko A, Marcucci M, McLeod SL, Motaghi S, Murthy S, Mustafa RA, Pardo-Hernandez H, Rada G, Rizwan Y, Saadat P, Switzer C, Thabane L, Tomlinson G, Vandvik PO, Vernooij RW, Viteri-García A, Wang Y, Yao L, Zhao Y, Guyatt GH, Brignardello-Petersen R. Drug treatments for covid-19 living systematic review and metanalysis. BMJ 2020; 370:m2980.
-3131 Furtado RHM, Berwanger O, Fonseca HA, Corrêa TD, Ferraz LR, Lapa MG, Zampieri FG, Veiga VC, Azevedo LCP, Rosa RG, Lopes RD, Avezum A, Manoel ALO, Piza FMT, Martins PA, Lisboa TC, Pereira AJ, Olivato GB, Dantas VCS, Milan EP, Gebara OCE, Amazonas RB, Oliveira MB, Soares RVP, Moia DDF, Piano LPA, Castilho K, Momesso RGRAP, Schettino GPP, Rizzo LV, Neto AS, Machado FR, Cavalcanti AB; COALITION COVID-19 Brazil II Investigators. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomized clinical trial. Lancet 2020; 396(10256):959-967.. The excessive use of certain medications can even increase the incidence of adverse effects, some of which can be fatal3030 Siemieniuk RA, Bartoszko JJ, Zeraatkar D, Kum E, Qasim A, Martinez JPD, Izcovich A, Lamontagne F, Han MA, Agarwal A, Agoritsas T, Azab M, Bravo G, Chu DK, Couban R, Devji T, Escamilla Z, Foroutan F, Gao Y, Ge L, Ghadimi M, Heels-Ansdell D, Honarmand K, Hou L, Ibrahim Q, Khamis A, Lam B, Mansilla C, Loeb M, Miroshnychenko A, Marcucci M, McLeod SL, Motaghi S, Murthy S, Mustafa RA, Pardo-Hernandez H, Rada G, Rizwan Y, Saadat P, Switzer C, Thabane L, Tomlinson G, Vandvik PO, Vernooij RW, Viteri-García A, Wang Y, Yao L, Zhao Y, Guyatt GH, Brignardello-Petersen R. Drug treatments for covid-19 living systematic review and metanalysis. BMJ 2020; 370:m2980.,3232 Mitjà O, Corbacho-Monné M, Ubals M, Alemany A, Suñer C, Tebé C, Tobias A, Peñafiel J, Ballana E, Pérez CA, Admella P, Riera-Martí N, Laporte P, Mitjà J, Clua M, Bertran L, Sarquella M, Gavilán S, Ara J, Argimon JM, Cuatrecasas G, Cañadas P, Elizalde-Torrent A, Fabregat R, Farré M, Forcada A, Flores-Mateo G, López C, Muntada E, Nadal N, Narejos S, Nieto A, Prat N, Puig J, Quiñones C, Ramírez-Viaplana F, Reyes-Urueña J, Riveira-Muñoz E, Ruiz L, Sanz S, Sentís A, Sierra A, Velasco C, Vivanco-Hidalgo RM, Zamora J, Casabona J, Vall-Mayans M, González-Beiras C, Clotet B; BCN-PEP-CoV2 Research Group. A cluster- randomized trial of hydroxychloroquine for prevention of Covid-19. N Engl J Med 2021; 384(5):417-427..

In November 2021, under significant pressure from scientific organizations and media bodies, the National Commission for the Incorporation of Technologies into the Unified Health System (CONITEC) belatedly issued a public statement confirming that it did not recommend the use of the “COVID kit”3333 Comissão Nacional de Incorporação de Tecnologias no Sistema Único de Saúde. Relatório de recomendação: protocolos clínicos e diretrizes terapêuticas [Internet]. 2021. [acessado 2022 set 29]. Disponível em: https://www.gov.br/conitec/pt-br/midias/relatorios/diretrizesbrasileiras_tratamentohospitalarpaciente_capii.pdf.
https://www.gov.br/conitec/pt-br/midias/...
. The damage was already done from a public health point of view. The consequences are difficult to measure, including medicine shortages and treatment interruptions2020 Massuda A, Malik AM, Vecina G, Tasca R, Ferreira-Júnior WC. A resiliência do Sistema Único de Saúde frente à COVID-19. Cad EBAPE.BR 2021; 19(esp.):735-744..

Vaccination is one of the most effective ways of preventing the spread of the diseases and mitigating the effects of the pandemic. Brazil’s National Immunization Program (PNI) is one of the world’s largest and complete vaccination programs3434 Cruz A. A queda da Imunização no Brasil [Internet]. 2017. [acessado 2022 mar 3] Disponível em: https://portal.fiocruz.br/sites/portal.fiocruz.br/files/documentos/revistaconsensus_25_a_ queda_da_imunizacao.pdf
https://portal.fiocruz.br/sites/portal.f...
,3535 Sato APS. Qual a importância da hesitação vacinal na queda das coberturas vacinais no Brasil? Rev de Saude Publica 2018; 52:96.. The Brazilian government’s initial hesitation in acquiring vaccines authorized in other countries and the poor organization of and delays in vaccine distribution prolonged high hospitalization rates and contributed to deaths during pandemic3434 Cruz A. A queda da Imunização no Brasil [Internet]. 2017. [acessado 2022 mar 3] Disponível em: https://portal.fiocruz.br/sites/portal.fiocruz.br/files/documentos/revistaconsensus_25_a_ queda_da_imunizacao.pdf
https://portal.fiocruz.br/sites/portal.f...
,3535 Sato APS. Qual a importância da hesitação vacinal na queda das coberturas vacinais no Brasil? Rev de Saude Publica 2018; 52:96..

In 2020, a study with health professionals working in public services in Brazil showed that only 69.5% of nurses, 64.1% of doctors and 34.1% of community health workers had received personal protective equipment (PPE) on a continuous basis during the pandemic. Only 65% of invisible health workers (IHWs) were provided with PPE and received training in the proper use of equipment3636 Machado MH, coordenadora. Pesquisa: condições de trabalho dos profissionais de saúde no contexto da covid-19 no Brasil. Rio de Janeiro: ENSP/CEE-Fiocruz; 2020/2021.,3737 Machado MH, coordenadora. Pesquisa: os trabalhadores invisíveis da saúde: condições de trabalho e saúde mental no contexto da covid-19 no Brasil. Rio de Janeiro: ENSP/CEE-Fiocruz; 2021/2022. (Chart 1).

Chart 1
Health workers and invisible health workers within the context of the COVID-19 pandemic - Brazil (n = 15,132 and n = 21,480).

Guidance saying that only individuals with more severe symptoms should seek health services had an effect on the treatment of other chronic conditions2020 Massuda A, Malik AM, Vecina G, Tasca R, Ferreira-Júnior WC. A resiliência do Sistema Único de Saúde frente à COVID-19. Cad EBAPE.BR 2021; 19(esp.):735-744.. Services for other types of conditions had already been limited before the pandemic due to a reduction in the number of available medical appointments in primary care, home visits and vaccination coverage3838 Oliveira MLA, Abreu AL, Siqueira MM. A organização da vigilância laboratorial e a rede de laboratórios de Saúde Pública no contexto da pandemia de COVID-19. In: Profissionais de saúde e cuidados primários. Brasília: CONASS; 2021. [acessado 2022 ago 3]. Disponível em: https:// www.conass.org.br/biblioteca/volume-4-profissionais-de-saude-e-cuidados-primarios/.

Effects on the working conditions of health workers

The essence of health work is to care for life, human beings and society. To develop and deliver care for life, health systems need a huge and complex health work force (HWF) made up of a diverse range of professionals and specialists who require continuous training and development, and specific professional regulation. According to Machado, health care is currently in the “pre-professional citizenship stage”3636 Machado MH, coordenadora. Pesquisa: condições de trabalho dos profissionais de saúde no contexto da covid-19 no Brasil. Rio de Janeiro: ENSP/CEE-Fiocruz; 2020/2021.,3737 Machado MH, coordenadora. Pesquisa: os trabalhadores invisíveis da saúde: condições de trabalho e saúde mental no contexto da covid-19 no Brasil. Rio de Janeiro: ENSP/CEE-Fiocruz; 2021/2022..

There are deep inequalities between professionals: those with higher education, the visible; and the large contingent of professionals with technical qualifications, who are invisible and peripheral to the eyes of directors, managers and service users. IHWs generally work in unstable, low-paid outsourced jobs3636 Machado MH, coordenadora. Pesquisa: condições de trabalho dos profissionais de saúde no contexto da covid-19 no Brasil. Rio de Janeiro: ENSP/CEE-Fiocruz; 2020/2021.,3737 Machado MH, coordenadora. Pesquisa: os trabalhadores invisíveis da saúde: condições de trabalho e saúde mental no contexto da covid-19 no Brasil. Rio de Janeiro: ENSP/CEE-Fiocruz; 2021/2022., providing support for care activities. Different and unequal worlds interacting in the same health care setting.

The two studies conducted by FIOCRUZ mentioned above analyzed replies from 15,132 health professionals and 21,480 IHWs to a questionnaire about working conditions and mental health in the context of the COVID-19 pandemic. Most to the respondents were women 77.6% and 72.5% were IHWs (Box 1). Over half of the health professionals (57.7%) were white and 39.9% were brown or black, compared 36.6% and 59% of the IHWs, respectively. The largest numbers of health professionals are concentrated in the Southeast and Northeast and the smallest numbers in the Midwest and North (Chart 1).

The data show that 47.4% of health professionals and 50.9% of IHWs perform physically demanding tasks. Around 43% of health professionals and 53% of IHWs reported that they do not feel protected at work, while 27.6% and 37.3%, respectively, said they had not received training in the use of PPE (Chart 1).

The pandemic had a significant effect on the personal and professional well-being of health workers due to the daily contact with the disease and death, poor working conditions, exhausting workload and changes in work routine. The most common effects on the daily life of the HWF were sleep disturbance, irritability/crying/general disorders, and inability to relax/stress (Chart 1).

In the analysis of the data on mental health, symptoms were divided into two groups: depressive symptoms and anxiety disorder. Depressive symptoms were indicated by loss of job/life satisfaction (9.1% of health professionals and 7.2% of IHWs) and having a negative feeling about the future/life (8.3% of health professionals and 6.8% of IHWs). Anxiety disorder was indicated by changes in appetite/weight (8.1% of health professionals and 7.2% of IHWs), irritability, frequent crying and general disorders (13.6% of health professionals and 9.8% IHWs), difficulty concentrating or slower thinking (9.2% of health professionals and 7.2% of IHWs), inability to relax/stress (11.7% of health professionals and 9.7% of IHWs), anxiety, headaches and general pain (0.5% of health professionals and 9.7% of IHWs).

Sleep disturbance, understood as insomnia and hypersomnia, was the most common problem (15.8% of health professionals and 13% of IHWs). Respondents also reported a significant increase in the consumption of medicines, alcohol, energy drinks and cigarettes during the pandemic (6% of health professionals and 3.6% of IHWs), which can affect the health of these workers.

With regard to feelings in relation to professional life during the pandemic, 30.4% of health professionals and 35.5% of IHWs reported experiencing violence/discrimination. The latter was experienced at work (38.7% of health professionals and 36.2% of IHWs), on the way to work/home (27.6% of health professionals and 31.5% of IHWs), or from neighbors (33.7% of health professionals and 32.4% of IHWs).

With regard to professional appreciation, 16.7% of health professionals and 23.8% of IHWs felt less appreciated by the public and 21% of health professionals and 25.6% of IHWs felt less welcomed by directors/managers. Around 22% of health professionals and IHWs reported feeling more welcomed by health service users, 10% of health professionals and 8% of IHWs felt more welcomed by directors/managers, and 10% of health professionals and 7.1% of IHWs felt more respected by colleagues.

Around 43% of health professionals and 53% of IHWs felt unprotected, unsafe, fear of dying, and exposed to long and exhausting working hours and a hostile organizational climate (Chart 1).

The COVID-19 pandemic threatened people’s lives and imposed changes to the world of work in general. It had a particularly large impact on health work, changing the health care process, workers’ lives and well-being, and health and safety at work.

Saragih et al. (2021)3939 Saragih ID, Tonapa SI, Saragih IS, Advani S, Batubara SO, Suarilah I, Lin CJ. Global prevalence of mental health problems among healthcare workers during the Covid-19 pandemic: a systematic review and meta-analysis. Int J Nurs Stud 2021; 121:104002. conducted a systematic literature review to analyze the prevalence of mental health problems among healthcare workers during the COVID-19 pandemic. The distribution of workers included 27.9% doctors, 43.7% nurses and 7.0% allied health workers. The pooled prevalence of post-traumatic stress disorder, anxiety, depression, and distress was 49%, 40%, 37% and 37%, respectively.

A systematic review of 65 studies by Li et al. (2021)4040 Li Y, Scherer N, Felix L, Kupe H. Prevalence of depression, anxiety and posttraumatic stress disorder in health care workers during the COVID-19 pandemic: a systematic review and meta-analysis. PLoS One 2021; 16(3):e0246454. found that pooled prevalence of depression, anxiety and posttraumatic stress disorder was 21.7%, 22.1% and 21.5%, respectively.

The COVID-19 HEalth caRe wOrkErs Study (HEROES) conducted interviews with 14,502 health care workers from 11 Latin American countries. The findings show that the pandemic increased rates of stress, anxiety, depression, suicidal ideation and psychological distress among health workers and clearly showed the lack of specific policies to protect the mental health of these professionals4141 Organização Panamericana da Saúde (OPAS). O Covid-19 Health Care Workers Study (HEROES): Relatório Regional das Américas [Internet]. 2022. [acessado 2022 maio 9]. Disponível em: https://iris.paho.org/handle/10665.2/55972
https://iris.paho.org/handle/10665.2/559...
.

The Director of the WHO Health Workforce Department, James Campbell, said that “COVID-19 has exposed the cost of this systemic lack of safeguards for the health, safety and wellbeing of health workers”, when revealing that about 115,500 health workers died from COVID-19 in the first 18 months of the pandemic. In the same vein, the Director of the International Labor Organization’s Sectoral Policies Department, Alerte van Ler, declared that “Health workers, like all other workers, should enjoy their right to decent work, safe and healthy working environments and social protection for healthcare, sickness absence and occupational diseases and injuries”4242 Organização Mundia da Saúde (OMS), Organização Internacional do Trabalho (OIT). Guia de orientações para garantir a segurança no trabalho para os profissionais de saúde da OMS e da OIT. Lisboa: OMS/OIT; 2020..

On 22/10/2021, the WHO estimated that between 80,000 and 180,000 health and care workers could have died from COVID-19 between January 2020 and May 2021, not to mention the burnout, stress, anxiety, fatigue and poor working conditions experienced by these professionals. Proportionally, Brazil recorded the highest rate of death among this group.

According to Public Services International, more than 4,500 health professionals died in Brazil during the pandemic4343 Organização Mundial da Saúde (OMS). Ano Internacional dos Trabalhadores de Saúde e Cuidadores [Internet]. 2020. [acessado 2022 jul 23]. Disponível em: https://www.paho.org/pt/campanhas/ano- internacional-dos-trabalhadores-saude-e-cuidadores2021#:~: text=2021%20foi%20designado%20como%20o,na%20 capacidade%20da%20s ociedade%20de
https://www.paho.org/pt/campanhas/ano- i...
. Machado et al (2022)4444 Machado MH, Teixeira EG, Freire NP, Pereira EJ, Minayo MCS. Óbitos de médicos e da equipe de enfermagem por COVID-19 no Brasil: uma abordagem sociológica. Cien Saude Colet 2023; 28(2):405-419. analyzed data from the period March 2020-March 2021, reporting high COVID-19 mortality rates among doctors, nurses, and auxiliary nurses in Brazil. According to the Federal Medical Council and Federal Nursing Council, 622 doctors, 100 nurses and 470 auxiliary nurses died up to March 2023. Most of the doctors (87.6%) were male, while most of the auxiliary nurses (69.1%) were female. Rates among nurses were similar between genders: 59.5% women and 40.5% men (Table 1).

Table 1
Deaths of doctors, nurses and auxiliary nurses due to COVID-19 by sex - Brazil.

The words of WHO Director-General Dr Tedros Adhanom Ghebreyesus are emblematic: “No country, hospital or clinic can keep its patients safe unless it keeps its health workers safe. WHO’s Health Worker Safety Charter is a step towards ensuring that health workers have the safe working conditions, the training, the pay and the respect they deserve”. The protection of health professionals is essential to ensure the functioning of health systems and society4545 Organização Mundial da Saúde (OMS). Até 180 mil profissionais de saúde morreram de Covid-19, informa OMS [Internet]. 2021. [acessado 2022 out 7]. Disponível em: https://brasil.un.org/pt- br/152760-ate-180-mil-profissionais-de-saude-morreram-de-covid-19-informa-oms
https://brasil.un.org/pt- br/152760-ate-...
. Health systems are threatened by the shortage and exodus of experienced health professionals.

Infodemic and dissemination of fake news

The WHO coined the term infodemic in parallel with the COVID-19 pandemic to refer to an overabundance of information, including false or misleading information, during a disease outbreak.

Fake health news can be characterized as conspiracy theories, false cures, miracle foods and other dubious news that aggravate the spread of SARS-CoV-2, confusing citizens and encouraging them to ignore evidence-based treatments recommended by official health agencies.

Propagated by social media and messaging apps (Twitter, WhatsApp, Telegram, Facebook, YouTube, TikTok, LinkedIn, Viber, VK, Kwai), this phenomenon has called for an integrated and coordinated global response from governments, organizations and specialists.

Combating fake news is key to reducing the damage that the infodemic continues to cause, undermining confidence in health systems, health workers, treatment, diagnoses and vaccines.

The response lies in infodemiology4646 Freire NP, Cunha ICKO, Ximenes Neto FRG, Machado MH, Minayo CS. A infodemia transcende a pandemia. Cien Saude Colet 2021; 26(09):4065-4068., a branch of communications dedicated to delving deep into the internet in search of public health content posted by common users with the aim of monitoring information, improving news, translating scientific knowledge and carrying out systematic checks.

In response to this global problem, the WHO today recommends 5 ways to combat the stigma4747 World Health Organization (WHO). How to report misinformation online [Internet]. 2022. [cited 2023 jan 7]. Available from: https://www.who.int/campaigns/connecting-the-world-to-combat- coronavirus/how-to-report-misinformation-online
https://www.who.int/campaigns/connecting...
caused by the infodemic: 1) use social media listening to analyze what is being said, who is saying it and how it affects you; 2) use language carefully to avoid stigmatizing specific groups and perpetuating social or health inequalities; 3) involve members of communities at risk of being stigmatized in designing interventions aimed at them; 4) provide free content that promotes health equity; and 5) promote ways through which individuals and communities experiencing stigma, harassment and abuse can protect themselves online and report misinformation.

Keys to infodemic management4848 World Health Organization (WHO). WHO policy brief: COVID-19 infodemic management [Internet]. 2022. [cited 2022 set 14]. Available from: WHO/2019- nCoV/Policy_Brief/Infodemic/2022.1 include training health workers, as trusted sources of health information, to identify and address misinformation, tailoring health, information and digital literacy initiatives to specific populations, and debunking misinformation before it is widely disseminated.

An important initiative developed by FIOCRUZ to tackle the dissemination of fake news, misinformation and malicious manipulation of information was a workshop for journalists aimed at providing high-quality information about the health emergency to representatives of the country’s main media outlets4949 Valverde R. Oficina sobre coronavírus para jornalistas [Internet]. 2020. [acessado ano mês dia]. Disponível em: https://portal.fiocruz.br/noticia/fiocruz-oferece-oficina-sobre-coronavirus-para-jornalistas
https://portal.fiocruz.br/noticia/fiocru...
.

The two studies conducted by FIOCRUZ showed that 91.6% of the HWF agreed that fake health news was an obstacle to tackling the novel coronavirus. Around 76% of health professionals treated patients who believed fake news about COVID-19 and 68.5% disagreed with the positions taken by the country’s health authorities3636 Machado MH, coordenadora. Pesquisa: condições de trabalho dos profissionais de saúde no contexto da covid-19 no Brasil. Rio de Janeiro: ENSP/CEE-Fiocruz; 2020/2021.,3737 Machado MH, coordenadora. Pesquisa: os trabalhadores invisíveis da saúde: condições de trabalho e saúde mental no contexto da covid-19 no Brasil. Rio de Janeiro: ENSP/CEE-Fiocruz; 2021/2022..

Final considerations

The impact of the COVID-19 pandemic was greater in low-income countries and among marginalized groups. The pandemic underscored weaknesses in the funding, management and structure of the country’s health services. The interruption of essential health services, such as consultations and non-emergency surgeries, aggravated comorbidities and preventable deaths and led to a reduction in infectious disease testing. It is essential to promote actions to protect the health, safety and well-being of health workers, who are all too often exposed to poor working conditions and risk their own lives to save the lives of others. The infodemic, fake news and vaccine refusal should be effectively addressed in a systematic manner and access to correct true information should be improved.

The correlation between the factors mentioned above show that several variables can lead to burnout, chronic stress, anxiety disorders and depression among health workers. It is therefore crucial to ensure safe and healthy working conditions and emotional support to protect the mental health of workers during health crises. Other pandemics will come, and preparation should be ongoing.

Acknowledgements

We are grateful to the Lucas Machado Educational Foundation (FELUMA) for their support and incentive during the study and to Geralda Oliveira for her support.

References

  • 1
    Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. A new coronavirus associated with human respiratory disease in China. Nature 2020; 579(7798):265-269.
  • 2
    Brasil. Ministério da Saúde (MS). Portaria nº 188, de 3 de fevereiro de 2020. Declara Emergência em Saúde Pública de importância Nacional (ESPIN) em decorrência da Infecção Humana pelo novo Coronavírus (2019-nCoV). Saúde Legis 2020; 3 fev.
  • 3
    Brasil. Lei 13.979, de 6 de fevereiro de 2020. Dispõe sobre as medidas para enfrentamento da emergência de saúde pública de importância internacional decorrente do coronavírus responsável pelo surto de 2019. Diário Oficial da União 2020; 6 fev.
  • 4
    Genoma do SARS-CoV-2 do primeiro caso de COVID-19 da América Latina sequenciado em 48 horas no Instituto Adolfo Lutz [Internet]. Faculdade de Medicina da USP 2020. [acessado 2022 fev 8]. Disponível em: https://www.fm.usp.br/fmusp/noticias/-genoma-do-sars-cov-2-do-primeiro-caso-de-covid-19-da-america-latina-sequenciado-em-48-horas-no-instituto-adolfo-lutz
    » https://www.fm.usp.br/fmusp/noticias/-genoma-do-sars-cov-2-do-primeiro-caso-de-covid-19-da-america-latina-sequenciado-em-48-horas-no-instituto-adolfo-lutz
  • 5
    COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet 2022; 399(10334):1513-1536.
  • 6
    Gill I, Schellekens P. COVID-19 is a developing country pandemic [Internet]. 2021. [cited 2022 maio 27]. Available from: https://pandem-ic.com/blog-covid-19-is-a-developing-country-pandemic/
    » https://pandem-ic.com/blog-covid-19-is-a-developing-country-pandemic
  • 7
    Schellekens P. The demographics of excess mortality [Internet]. 2022. [cited 2022 ago 9]. Available at: https://pandem-ic.com/the-demographics-of-excess-mortality/
    » https://pandem-ic.com/the-demographics-of-excess-mortality
  • 8
    Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management BMJ 2021; 374:n1648.
  • 9
    Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol 2022; 322(1):C1-C11.
  • 10
    Davis HE, Assaf GS, McCorkell L, Wei H, Baixo RJ, Re'em Y, Redfield S, Austin JP, Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021; 38:101019.
  • 11
    Johnson AG, Amin AB, Ali AR, Hoots B, Cadwell BL, Arora S, Avoundjian T, Awofeso AO, Barnes J, Bayoumi NS, Busen K, Chang C, Cima M, Crockett M, Cronquist A, Davidson S, Davis E, Delgadillo J, Dorabawila V, Drenzek C, Eisenstein L, Fast HE, Gent A, Hand J, Hoefer D, Holtzman C, Jara A, Jones A, Kamal-Ahmed I, Kangas S, Kanishka F, Kaur R, Khan S, King J, Kirkendall S, Klioueva A, Kocharian A, Kwon FY, Logan J, Lyons BC, Lyons S, May A, McCormick D; MSHI; Mendoza E, Milroy L, O'Donnell A, Pike M, Pogosjans S, Saupe A, Sell J, Smith E, Sosin DM, Stanislawski E, Steele MK, Stephenson M, Stout A, Strand K, Tilakaratne BP, Turner K, Vest H, Warner S, Wiedeman C, Zaldivar A, Silk BJ, Scobie HM. COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of delta and omicron variant emergence - 25 U.S. jurisdictions April 4-December 25, 2021. MMWR Morb Mortal Wkly Rep 2022; 71(4):132-138.
  • 12
    Watson OJ, Barnsley G, Toor J, Hogan AB, Wisnkill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Inf Dis 2022; 22(9):1293-302.
  • 13
    Moore S, Hill EM, Dyson L, Tildesley M.J, Keeling MJ. Retrospectively modeling the effects of increased global vaccine sharing on the COVID-19 pandemic. Nature Med 2022; 28(11):2416-2423.
  • 14
    Omboni S, Padwal RS, Alessa T, Benczúr B, Green BB, Hubbard I, Kario K, Khan NA, Konradi A, Logan AG, Lu Y, Mars M, McManus RJ, Melville S, Neumann CL, Parati G, Renna NF, Ryvlin P, Saner H, Schutte AE, Wang J. Connect Health 2022; 1:7-35.
  • 15
    United Nations Children's Fund (UNICEF), United Nations Educational, Scientific and Cultural Organization (UNESCO), World Bank. Where are we on education recovery? New York: UNICEF; 2022.
  • 16
    Croda J, Oliveira WK, Frutuoso RL, Mandetta LH, Silva DCB, Sousa JDB, Monteiro WM, Lacerda MVG. COVID-19 in Brazil: advantages of a socialized unified health systemand preparation to contain cases. Rev Soc Bras de Med Trop 2020; 53: e20200167.
  • 17
    Wakimoto MD, Menezes RC, Pereira SA, Nery T, Castro-Alves J, Penetra SLS, Ruckert A, Labonté R, Veloso VG. COVID-19 and zoonoses in Brazil: environmental scan of one health preparedness and response. One Health 2022; 14:100400.
  • 18
    Tasca R, Carrera MBM, Malik AM, Schiesari LMC, Bigoni A, Costa CF, Massuda A. Gerenciando o SUS no nível municipal ante a COVID-19: uma análise preliminar. Saude Debate 2022; 46(esp. 1):15-32.
  • 19
    Fundação Oswaldo Cruz (Fiocruz). Instituto de Comunicação e Informação Científica e Tecnológica em Saúde (ICICT) [Internet]. MonitoraCovid-19. 2020. [acessado 2023 jan 26] Disponível em: https://bigdata- covid19.icict.fiocruz.br/
    » https://bigdata- covid19.icict.fiocruz.br
  • 20
    Massuda A, Malik AM, Vecina G, Tasca R, Ferreira-Júnior WC. A resiliência do Sistema Único de Saúde frente à COVID-19. Cad EBAPE.BR 2021; 19(esp.):735-744.
  • 21
    Brizzi A, Whittaker C, Servo LMS, Hawryluk I, Prete Jr CA, Souza WM, Aguiar RS, Araujo LJT, Bastos LS, Blenkinsop A, Buss LF, Candido D, Castro MC, Costa SF, Croda J, de Souza Santos AA, Dye C, Flaxman S, Fonseca PLC, Geddes VEV, Gutierrez B, Lemey P, Levin AS, Mellan T, Bonfim DM, Miscouridou X, Mishra S, Monod M, Moreira FRR, Nelson B, Pereira RHM, Ranzani O, Schnekenberg RP, Semenova E, Sonabend R, Souza RP, Xi X, Sabino EC, Faria NR, Bhatt S, Ratmann O. Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals. Nat Med 2022; 28(7):1476-1485.
  • 22
    Lavras C. Atuação das equipes de APS durante o período de enfrentamento da COVID-19. In: Conselho Nacional de Secretários de Saúde (CONASS). Profissionais de saúde e cuidados primários. Brasília: CONASS; p. 13-24
  • 23
    Caetano R, Silva AB, Guedes ACCM, Paiva CCN, Ribeiro GR, Santos DL, Silva RM. Desafios e oportunidades para telessaúde em tempos da pandemia pela COVID-19: uma reflexão sobre os espaços e iniciativas no contexto brasileiro. Cad Saude Publica 2020; 36(5):e00088920.
  • 24
    Kameda K, Barbeitas MM, Caetano R, Löwy I, Oliveira ACD, Corrêa MCDV, Cassier M. Testing COVID-19 in Brazil: fragmented efforts and challenges to expand diagnostic capacity at the Brazilian Unified National Health System. Cad Saude Publica 2021; 37(3):e00277420.
  • 25
    Cotrim Júnior DF, Cabral LMS. Crescimento dos leitos de UTI no país durante a pandemia de COVID-19: desigualdades entre o público X privado e iniquidades regionais. Physis 2020; 30(3):e300317.
  • 26
    Passos VMA, Brant LCC, Pinheiro PC, Correa PRL, Machado IE, Santos MR, et al. Higher mortality during COVID-19 pandemic in socially vulnerable areas in Belo Horizonte: implications for vaccination priority. Rev Bras Epidemiol 2021; 24:e210025.
  • 27
    Conselho Federal de Medicina (CFM). Processo-consulta CFM nº 8/2020 - Parecer CFM nº 4/2020. Considerar o uso da cloroquina e hidroxicloroquina, em condições excepcionais, para o tratamento da COVID-19 [Internet]. 2020. Disponível em: https://saude.mppr.mp.br/arquivos/File/Corona/CFM/6.pdf
    » https://saude.mppr.mp.br/arquivos/File/Corona/CFM/6.pdf
  • 28
    Cavalcanti AB, Zampieri FG, Rosa RG, Azevedo LCP, Veiga VC, Avezum A, Damiani LP, Marcadenti A, Kawano-Dourado L, Lisboa T, Junqueira DLM, de Barros E Silva PGM, Tramujas L, Abreu-Silva EO, Laranjeira LN, Soares AT, Echenique LS, Pereira AJ, Freitas FGR, Gebara OCE, Dantas VCS, Furtado RHM, Milan EP, Golin NA, Cardoso FF, Maia IS, Hoffmann Filho CR, Kormann APM, Amazonas RB, Bocchi de Oliveira MF, Serpa-Neto A, Falavigna M, Lopes RD, Machado FR, Berwanger O; Coalition Covid-19 Brazil I Investigators. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate COVID-19. N Engl J Med 2020; 383(21):2042-2052.
  • 29
    Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, Ustianowski A, Elmahi E, Prudon B, Whitehouse T, Felton T, Williams J, Faccenda J, Underwood J, Baillie JK, Chappell LC, Faust SN, Jaki T, Jeffery K, Lim WS, Montgomery A, Rowan K, Tarning J, Watson JA, White NJ, Juszczak E, Haynes R, Landray MJ. Effect of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 2020; 383(21):2030-2040.
  • 30
    Siemieniuk RA, Bartoszko JJ, Zeraatkar D, Kum E, Qasim A, Martinez JPD, Izcovich A, Lamontagne F, Han MA, Agarwal A, Agoritsas T, Azab M, Bravo G, Chu DK, Couban R, Devji T, Escamilla Z, Foroutan F, Gao Y, Ge L, Ghadimi M, Heels-Ansdell D, Honarmand K, Hou L, Ibrahim Q, Khamis A, Lam B, Mansilla C, Loeb M, Miroshnychenko A, Marcucci M, McLeod SL, Motaghi S, Murthy S, Mustafa RA, Pardo-Hernandez H, Rada G, Rizwan Y, Saadat P, Switzer C, Thabane L, Tomlinson G, Vandvik PO, Vernooij RW, Viteri-García A, Wang Y, Yao L, Zhao Y, Guyatt GH, Brignardello-Petersen R. Drug treatments for covid-19 living systematic review and metanalysis. BMJ 2020; 370:m2980.
  • 31
    Furtado RHM, Berwanger O, Fonseca HA, Corrêa TD, Ferraz LR, Lapa MG, Zampieri FG, Veiga VC, Azevedo LCP, Rosa RG, Lopes RD, Avezum A, Manoel ALO, Piza FMT, Martins PA, Lisboa TC, Pereira AJ, Olivato GB, Dantas VCS, Milan EP, Gebara OCE, Amazonas RB, Oliveira MB, Soares RVP, Moia DDF, Piano LPA, Castilho K, Momesso RGRAP, Schettino GPP, Rizzo LV, Neto AS, Machado FR, Cavalcanti AB; COALITION COVID-19 Brazil II Investigators. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomized clinical trial. Lancet 2020; 396(10256):959-967.
  • 32
    Mitjà O, Corbacho-Monné M, Ubals M, Alemany A, Suñer C, Tebé C, Tobias A, Peñafiel J, Ballana E, Pérez CA, Admella P, Riera-Martí N, Laporte P, Mitjà J, Clua M, Bertran L, Sarquella M, Gavilán S, Ara J, Argimon JM, Cuatrecasas G, Cañadas P, Elizalde-Torrent A, Fabregat R, Farré M, Forcada A, Flores-Mateo G, López C, Muntada E, Nadal N, Narejos S, Nieto A, Prat N, Puig J, Quiñones C, Ramírez-Viaplana F, Reyes-Urueña J, Riveira-Muñoz E, Ruiz L, Sanz S, Sentís A, Sierra A, Velasco C, Vivanco-Hidalgo RM, Zamora J, Casabona J, Vall-Mayans M, González-Beiras C, Clotet B; BCN-PEP-CoV2 Research Group. A cluster- randomized trial of hydroxychloroquine for prevention of Covid-19. N Engl J Med 2021; 384(5):417-427.
  • 33
    Comissão Nacional de Incorporação de Tecnologias no Sistema Único de Saúde. Relatório de recomendação: protocolos clínicos e diretrizes terapêuticas [Internet]. 2021. [acessado 2022 set 29]. Disponível em: https://www.gov.br/conitec/pt-br/midias/relatorios/diretrizesbrasileiras_tratamentohospitalarpaciente_capii.pdf
    » https://www.gov.br/conitec/pt-br/midias/relatorios/diretrizesbrasileiras_tratamentohospitalarpaciente_capii.pdf
  • 34
    Cruz A. A queda da Imunização no Brasil [Internet]. 2017. [acessado 2022 mar 3] Disponível em: https://portal.fiocruz.br/sites/portal.fiocruz.br/files/documentos/revistaconsensus_25_a_ queda_da_imunizacao.pdf
    » https://portal.fiocruz.br/sites/portal.fiocruz.br/files/documentos/revistaconsensus_25_a_ queda_da_imunizacao.pdf
  • 35
    Sato APS. Qual a importância da hesitação vacinal na queda das coberturas vacinais no Brasil? Rev de Saude Publica 2018; 52:96.
  • 36
    Machado MH, coordenadora. Pesquisa: condições de trabalho dos profissionais de saúde no contexto da covid-19 no Brasil. Rio de Janeiro: ENSP/CEE-Fiocruz; 2020/2021.
  • 37
    Machado MH, coordenadora. Pesquisa: os trabalhadores invisíveis da saúde: condições de trabalho e saúde mental no contexto da covid-19 no Brasil. Rio de Janeiro: ENSP/CEE-Fiocruz; 2021/2022.
  • 38
    Oliveira MLA, Abreu AL, Siqueira MM. A organização da vigilância laboratorial e a rede de laboratórios de Saúde Pública no contexto da pandemia de COVID-19. In: Profissionais de saúde e cuidados primários. Brasília: CONASS; 2021. [acessado 2022 ago 3]. Disponível em: https:// www.conass.org.br/biblioteca/volume-4-profissionais-de-saude-e-cuidados-primarios/
  • 39
    Saragih ID, Tonapa SI, Saragih IS, Advani S, Batubara SO, Suarilah I, Lin CJ. Global prevalence of mental health problems among healthcare workers during the Covid-19 pandemic: a systematic review and meta-analysis. Int J Nurs Stud 2021; 121:104002.
  • 40
    Li Y, Scherer N, Felix L, Kupe H. Prevalence of depression, anxiety and posttraumatic stress disorder in health care workers during the COVID-19 pandemic: a systematic review and meta-analysis. PLoS One 2021; 16(3):e0246454.
  • 41
    Organização Panamericana da Saúde (OPAS). O Covid-19 Health Care Workers Study (HEROES): Relatório Regional das Américas [Internet]. 2022. [acessado 2022 maio 9]. Disponível em: https://iris.paho.org/handle/10665.2/55972
    » https://iris.paho.org/handle/10665.2/55972
  • 42
    Organização Mundia da Saúde (OMS), Organização Internacional do Trabalho (OIT). Guia de orientações para garantir a segurança no trabalho para os profissionais de saúde da OMS e da OIT. Lisboa: OMS/OIT; 2020.
  • 43
    Organização Mundial da Saúde (OMS). Ano Internacional dos Trabalhadores de Saúde e Cuidadores [Internet]. 2020. [acessado 2022 jul 23]. Disponível em: https://www.paho.org/pt/campanhas/ano- internacional-dos-trabalhadores-saude-e-cuidadores2021#:~: text=2021%20foi%20designado%20como%20o,na%20 capacidade%20da%20s ociedade%20de
    » https://www.paho.org/pt/campanhas/ano- internacional-dos-trabalhadores-saude-e-cuidadores2021#:~: text=2021%20foi%20designado%20como%20o,na%20 capacidade%20da%20s ociedade%20de
  • 44
    Machado MH, Teixeira EG, Freire NP, Pereira EJ, Minayo MCS. Óbitos de médicos e da equipe de enfermagem por COVID-19 no Brasil: uma abordagem sociológica. Cien Saude Colet 2023; 28(2):405-419.
  • 45
    Organização Mundial da Saúde (OMS). Até 180 mil profissionais de saúde morreram de Covid-19, informa OMS [Internet]. 2021. [acessado 2022 out 7]. Disponível em: https://brasil.un.org/pt- br/152760-ate-180-mil-profissionais-de-saude-morreram-de-covid-19-informa-oms
    » https://brasil.un.org/pt- br/152760-ate-180-mil-profissionais-de-saude-morreram-de-covid-19-informa-oms
  • 46
    Freire NP, Cunha ICKO, Ximenes Neto FRG, Machado MH, Minayo CS. A infodemia transcende a pandemia. Cien Saude Colet 2021; 26(09):4065-4068.
  • 47
    World Health Organization (WHO). How to report misinformation online [Internet]. 2022. [cited 2023 jan 7]. Available from: https://www.who.int/campaigns/connecting-the-world-to-combat- coronavirus/how-to-report-misinformation-online
    » https://www.who.int/campaigns/connecting-the-world-to-combat- coronavirus/how-to-report-misinformation-online
  • 48
    World Health Organization (WHO). WHO policy brief: COVID-19 infodemic management [Internet]. 2022. [cited 2022 set 14]. Available from: WHO/2019- nCoV/Policy_Brief/Infodemic/2022.1
  • 49
    Valverde R. Oficina sobre coronavírus para jornalistas [Internet]. 2020. [acessado ano mês dia]. Disponível em: https://portal.fiocruz.br/noticia/fiocruz-oferece-oficina-sobre-coronavirus-para-jornalistas
    » https://portal.fiocruz.br/noticia/fiocruz-oferece-oficina-sobre-coronavirus-para-jornalistas

Publication Dates

  • Publication in this collection
    23 Oct 2023
  • Date of issue
    Oct 2023

History

  • Received
    20 Oct 2022
  • Accepted
    01 June 2023
  • Published
    28 June 2023
ABRASCO - Associação Brasileira de Saúde Coletiva Rio de Janeiro - RJ - Brazil
E-mail: revscol@fiocruz.br